Thus, they concluded that increasing expression of FAP in lesions with a higher degree of malignancy matches the expectation of a stronger FAP expression in PDAC and high-grade IPMNs than in low-grade IPMN [127]. This evidence concerns the gene FAP and pancreatic intraductal papillary-mucinous neoplasm.